Acera Surgical Stock
Develop a portfolio of fully synthetic surgical materials that act as nano-scale scaffold for tissue regeneration.
Sign up today and learn more about Acera Surgical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Acera Surgical Stock
Acera Surgical, Inc. has developed a portfolio of fully synthetic surgical materials that act as resorbable scaffolds for soft tissue repair and regeneration. Acera's products are designed to improve surgical efficiency, reduce surgical complications and cost, and facilitating superior clinical outcomes.
Funding History
August 2013 | $600K |
---|---|
October 2018 | $5.1M |
Management
Founder , President & CSO
Matthew MacEwan
Manager, Program Development
Wenqi Yue
Vice President, Business Development
Julie Cochran
Director, Product Development
Tamas Kovacs
CEO
Agnes Rey-Giraud
Press
artrocker - Feb, 1 2024
Dural Graft Implant Market Size, Dynamics of Technological ...artrocker - Feb, 1 2024
Orthopedic Cartilage Repair Industry Forecast (2023-2030 ...biospace - May, 12 2022
Acera Surgical Announces Michael Finegan as New CEO24-7pressrelease - Apr, 8 2018
Acera Surgical Inc. Gets Listed on THE OCMX™prnewswire - May, 22 2016
Hernia Repair Market Medical Devices Pipeline Assessment 2016 Research Report